Chronic Suppressive Antibiotic Treatment for Staphylococcal Bone and Joint Implant–Related Infections

Prosthetic joint infection (PJI) and fracture-related infection (FRI) are difficult-to-treat conditions in patients with severe comorbidity or significant surgical risk. In cases not eligible for standard strategy, debridement procedures with the retention of prosthesis or internal fixation device, combined with long-term antibiotic treatment and subsequent indefinite chronic oral antimicrobial suppression (COAS), can be the only reasonable choice. The aim of this study was to investigate the role of COAS and its follow-up in the management of these cases. We retrospectively analyzed a cohort of 16 patients with a follow-up of at least 6 months (mean age 75 yo, 9F, 7M, 11 PJI, 5 FRI). All microbiological isolates were tetracycline-susceptible staphylococci and for this reason a minocycline-based COAS was adopted after debridement and 3 months of antibiogram-guided antibiotic treatment. Patient monitoring was carried out on a clinical basis, with bimonthly execution of the inflammation indices and serial radiolabeled leukocyte scintigraphy (LS). The overall median time of COAS follow-up was 15 months (min 6–max 30). Moreover, 62.5% of patients were still taking COAS with no relapse after cure at the last evaluation available. Clinical failure with a relapse of the infection was observed in 37.5% of patients; interestingly, 50% of them had previously stopped COAS due to side effects of the antibiotic used. In the COAS follow-up, a combination of clinical, laboratory and LS evaluation seems to monitor the infection properly. COAS can be considered as an interesting approach in patients not suitable for standard treatments of PJI or FRI but it requires careful monitoring.

[1]  Robin Patel Periprosthetic Joint Infection. , 2023, The New England journal of medicine.

[2]  G. Toro,et al.  Periprosthetic knee infection: treatment options. , 2022, Orthopedic reviews.

[3]  M. Bhandari,et al.  The management of fracture related infections: What practices can be supported by high-level evidence? , 2022, Journal of orthopaedic surgery.

[4]  S. Nandi,et al.  Retention of Minocycline Susceptibility When Gram-Positive Periprosthetic Joint Infection Isolates Are Non-Susceptible to Doxycycline , 2022, Infectious disease reports.

[5]  Angela L Hewlett,et al.  Excellent Outcomes With the Selective Use of Oral Antibiotic Therapy for Bone and Joint Infections: A Single-Center Experience , 2022, Cureus.

[6]  A. Dhand,et al.  Re-establishing the utility of tetracycline-class antibiotics for current challenges with antibiotic resistance , 2022, Annals of medicine.

[7]  C. Davies,et al.  Tetracyclines and bone: Unclear actions with potentially lasting effects. , 2022, Bone.

[8]  E. Delmastro,et al.  Management of prosthetic joint infections: a guidelines comparison , 2022, MUSCULOSKELETAL SURGERY.

[9]  E. D. Di Domenico,et al.  Biofilm-Related Infections in Gram-Positive Bacteria and the Potential Role of the Long-Acting Agent Dalbavancin , 2021, Frontiers in Microbiology.

[10]  Á. Soriano,et al.  The efficacy of suppressive antibiotic treatment in patients managed non-operatively for periprosthetic joint infection and a draining sinus , 2021, Journal of bone and joint infection.

[11]  K. Kline,et al.  Eradicating biofilm infections: an update on current and prospective approaches. , 2021, Current opinion in microbiology.

[12]  J. Cobo,et al.  Suppressive Antibiotic Treatment in Prosthetic Joint Infections: A Perspective , 2021, Antibiotics.

[13]  I. Savitcheva,et al.  Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection , 2021, Nuclear medicine communications.

[14]  D. Khanna,et al.  Minocycline and doxycycline: More Than Antibiotics. , 2021, Current molecular pharmacology.

[15]  M. R. Dominic Adverse Reactions Induced by Minocycline: A Review of Literature. , 2021, Current drug safety.

[16]  Á. Soriano,et al.  The EBJIS definition of periprosthetic joint infection , 2021, The bone & joint journal.

[17]  G. Kelsberg,et al.  Potential harms of long-term acne treatment with oral antibiotics. , 2020, Canadian family physician Medecin de famille canadien.

[18]  M. Gismondo,et al.  Microbial biofilm correlates with an increased antibiotic tolerance and poor therapeutic outcome in infective endocarditis , 2019, BMC Microbiology.

[19]  S. Gill,et al.  Evolving concepts in bone infection: redefining “biofilm”, “acute vs. chronic osteomyelitis”, “the immune proteome” and “local antibiotic therapy” , 2019, Bone Research.

[20]  O. Borens,et al.  Periprosthetic joint infection: current concepts and outlook , 2019, EFORT open reviews.

[21]  B. Klatt,et al.  Benefits and Adverse Events Associated with Extended Antibiotic Use in Total Knee Arthroplasty Periprosthetic Joint Infection. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  É. Senneville,et al.  Hip and Knee Section, Treatment, Antimicrobial Suppression: Proceedings of International Consensus on Orthopedic Infections. , 2019, The Journal of arthroplasty.

[23]  K. LaPlante,et al.  Biofilm prevention concentrations (BPC) of minocycline compared to polymyxin B, meropenem, and amikacin against Acinetobacter baumannii. , 2019, Diagnostic microbiology and infectious disease.

[24]  Olivier Gheysens,et al.  Consensus document for the diagnosis of prosthetic joint infections: a joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement) , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  D. Berry,et al.  Irrigation and debridement with chronic antibiotic suppression for the management of infected total knee arthroplasty: A CONTEMPORARY ANALYSIS , 2018, The bone & joint journal.

[26]  M. Titécat,et al.  Suppressive antibiotic therapy with oral tetracyclines for prosthetic joint infections: a retrospective study of 78 patients , 2018, Infection.

[27]  R. G. Richards,et al.  Fracture-related infection: A consensus on definition from an international expert group. , 2017, Injury.

[28]  V. Prendki,et al.  Efficacy of indefinite chronic oral antimicrobial suppression for prosthetic joint infection in the elderly: a comparative study. , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[29]  M. Liberatore,et al.  99mTc-labeled White Blood Cell Scan as a Guide to Open Biopsy in the Management of Hip and Knee Prosthesis Infection: Preliminary Results. , 2017, Current radiopharmaceuticals.

[30]  P. Jutte,et al.  Efficacy of Antibiotic Suppressive Therapy in Patients with a Prosthetic Joint Infection , 2017, Journal of bone and joint infection.

[31]  M. Beilke,et al.  Prolonged oral antibiotic suppression in osteomyelitis and associated outcomes in a Veterans population. , 2015, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[32]  W. Barsoum,et al.  Chronic Suppression of Periprosthetic Joint Infections with Oral Antibiotics Increases Infection-Free Survivorship. , 2015, The Journal of bone and joint surgery. American volume.

[33]  A. Horswill,et al.  Staphylococcus aureus biofilms: recent developments in biofilm dispersal , 2014, Front. Cell. Infect. Microbiol..

[34]  David Lebeaux,et al.  Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics , 2014, Microbiology and Molecular Reviews.

[35]  J. Hirschfeld Dynamic interactions of neutrophils and biofilms , 2014, Journal of oral microbiology.

[36]  W. Ko,et al.  Efficacy of combination oral antimicrobial agents against biofilm-embedded methicillin-resistant Staphylococcus aureus. , 2013, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[37]  J. Ariza,et al.  Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[38]  C. Türkmen,et al.  The Additional Value of Tc 99m HMPAO White Blood Cell SPECT in the Evaluation of Bone and Soft Tissue Infections , 2011, Molecular imaging and radionuclide therapy.

[39]  Ora Israel,et al.  Guidelines for the labelling of leucocytes with 99mTc-HMPAO , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[40]  A. Aboderin,et al.  Therapeutic decision in chronic osteomyelitis: sinus track culture versus intraoperative bone culture , 2009, Archives of Orthopaedic and Trauma Surgery.

[41]  P. Bejon,et al.  One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome , 2009, The Journal of antimicrobial chemotherapy.

[42]  D. Rubello,et al.  Reliability of white blood cell scan in the follow-up of osteomyelitis. , 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[43]  D. Rubello,et al.  White blood cell scan in the follow-up of infectious diseases: is the withdrawal of antibiotic therapy necessary? , 2007, Nuclear medicine communications.

[44]  M. Liberatore,et al.  Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[45]  P. Baiocchi,et al.  Conservative Medical Therapy of Infections Following Osteosynthesis: a Retrospective Analysis of a Six-Year Experience , 2002, Journal of chemotherapy.

[46]  Ora Israel,et al.  Guidelines for the labelling of leucocytes with (99m)Tc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. , 2010, European journal of nuclear medicine and molecular imaging.